Make your money go further for just 25p per day

AIM IHT

Steaming ahead

22/09/2021 · Eagle Eye Solutions (EYE)  · IXICO (IXI)  · Mission Group (TMG)  · Nexteq (NXQ)  · Strix (KETL)  · Warpaint London (W7L) 

AIM AIM Inheritance Tax potential Technology UK

Boiling kettle

While some companies covered here are still in recovery mode, others have demonstrated admirable resilience and even thrived in the new environment. Our pick of the day is a fast-growing provider of technology to the retail sector while a data analytics company delivering insights in neuroscience also continues to impress (Free to read)


Mission Group: value trap or bargain?

Marketing communications and advertising specialists Mission Group (LON: TMG), announced encouraging interim results and there were mercifully fewer adjustments than previous years – our previous Blog here - Mission Marketing offers another horror show of adjustments - highlighted the previous issues with this business.

Despite significant disruption from the pandemic revenues for the six months ending 30 June rose 17.8% to £34.1m with headline operating profit…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Eagle Eye Solutions

Upgrades galore | Litigation bounce | Big ambitions

20/01/2026 · Company Insights

While Trump’s latest threats disturb stock markets, AIM companies covered here are trading well bringing upgrades…


AIM new arrival | Excellent update | Big warning

14/01/2025 · Company Insights

2024 was another difficult year for London’s junior stock market with plenty of departures and few…


More on IXICO

Bonkers Bargain: shares climb on contract win

17/11/2025 · Company Insights

This small medical imaging advanced analytics company delivering insights in neuroscience has loads of potential and…


Cash flow delights | Modestly valued | Growth expectations

27/02/2025 · Company Insights

News here includes our coverage of results from a large veterinary group, whose shares remain under…


More on Mission Group

Terrible communication | Another low-ball offer | Director buying

25/10/2023 · Company Insights

News covered in our free update here includes an unexpected profit warning from a communications agency…


Bonkers Bargain impresses | Modestly valued marketing

29/09/2023 · Company Insights

News covered here includes our thoughts on results from several modestly valued companies from the marketing…


More on Nexteq

Intoxicating development | Anything left for shareholders? | Selling the silver

19/12/2025 · Company Insights

News covered here includes our assessment of results from a heavily indebted flooring group where debt…


Appealing dividends | Big director buying

12/09/2025 · Company Insights

News covered here incudes our assessment of encouraging interim results from Fevertree Drinks – one Director…


More on Strix

Intoxicating development | Anything left for shareholders? | Selling the silver

19/12/2025 · Company Insights

News covered here includes our assessment of results from a heavily indebted flooring group where debt…


Impressive results | Trading well | Little to cheer

01/05/2025 · Company Insights

News covered here includes our assessment of excellent results from a provider of compliance and e-learning…


More on Warpaint London

Appealing dividends | Big director buying

12/09/2025 · Company Insights

News covered here incudes our assessment of encouraging interim results from Fevertree Drinks – one Director…


Big Buyback | Cosmetic growth | Back in tune?

29/04/2025 · Company Insights

News covered here includes our assessment of the latest trading update and share buyback from AIM’s…


More Company Insights

Neuroscience company with exciting potential

20/01/2026 · Cambridge Cognition

More on Eagle Eye Solutions

Upgrades galore | Litigation bounce | Big ambitions

AIM new arrival | Excellent update | Big warning

Flush with cash | Special dividends | Corporate undertakers

Fast growers | Big dividends

More on IXICO

Bonkers Bargain: shares climb on contract win

Cash flow delights | Modestly valued | Growth expectations

Important partners | Attractive valuation | Bonkers Bargains

10% dividend yield | Another brand buy | Frasers falls

More on Mission Group

Terrible communication | Another low-ball offer | Director buying

Bonkers Bargain impresses | Modestly valued marketing

Clean reporting | Veterinary growth

Whopping dividends from AIM

More on Nexteq

Intoxicating development | Anything left for shareholders? | Selling the silver

Appealing dividends | Big director buying

Survival of an innovator | Veterinary reassurance | Broker reluctance

Gold winner | Entrepreneurial success | CEO suspension

More on Strix

Intoxicating development | Anything left for shareholders? | Selling the silver

Impressive results | Trading well | Little to cheer

Effervescent news | Stitched up | Looking good

Victoria delivers a train crash of results

More on Warpaint London

Appealing dividends | Big director buying

Big Buyback | Cosmetic growth | Back in tune?

Challenges in the US | Plenty to like

Cosmetic ambiguity | Public sector winner and loser

More Company Insights

Upgrades galore | Litigation bounce | Big ambitions
Neuroscience company with exciting potential
Hostel to fortune | Assessing options | 7% dividend yield

Sign-up to our free email updates

SIGN UP